Skip to main content
. 2020 Mar 10;9(8):850–866. doi: 10.1002/sctm.19-0391

Table 3.

Studies applying ultrasound to mesenchymal stromal cells (MSCs) or MSC‐based therapies, organized by organ system

Organ system DUS LIUS HIFU ESWT
+MB −MB +MB −MB +MB
Adipose [89, 94]
Bone [46, 66, 72, 81, 82, 83, 84, 85, 89, 90, 96, 97, 98] [60, 77, 86, 87, 88, 99]
Cartilage [67, 78, 79, 81, 91, 92, 93, 98, 100]
CNS [76, 95] [45, 101] [54, 59]
Heart [63, 102] [40] [44, 47, 48, 49, 50, 62, 103] [52, 53]
Kidney [36] [38, 57, 64, 104] [61, 105]
Liver [75]
Muscle [37, 39, 41, 43, 64] [35, 51]
Pancreas [42]
Urogenital [58] [55, 56, 71]
Undifferentiated [65, 68, 73, 74, 80] [69, 70]

Abbreviations: CNS, central nervous system; DUS, diagnostic ultrasound; ESWT, extracorporeal shockwave therapy; HIFU, high‐intensity focused ultrasound; LIUS, low‐intensity ultrasound; MB, microbubble.